To delineate timing of motor decline in CLN3 disease. Motor function, assessed by the 6-Minute Walk Test (6MWT), was evaluated repeatedly in 15 patients with CLN3 disease, resulting in 65 test results Show more
To delineate timing of motor decline in CLN3 disease. Motor function, assessed by the 6-Minute Walk Test (6MWT), was evaluated repeatedly in 15 patients with CLN3 disease, resulting in 65 test results and during one occasion in 2 control cohorts. One control cohort (n = 14) had isolated visual impairment; a second cohort (n = 12) exhibited visual impairment in combination with neurologic impairments. Based on 6MWT reference values in healthy sighted children, In CLN3 disease, 6MWT scores were already impaired from first testing near diagnosis (mean The 6MWT unveils early onset of motor decline in CLN3 disease. Show less